Circulatory effect of TCS-80, a new imidazoline compound, in rats

Pharmacol Rep. 2016 Aug;68(4):715-9. doi: 10.1016/j.pharep.2016.03.008. Epub 2016 Mar 23.

Abstract

Background: Synthesis and hypotensive properties of centrally acting imidazoline agents: 1-[(imidazolidin-2-yl)imino]-1H-indazole (Marsanidine) and 7-chloro-1-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-1H-indazole (TCS-80) were tested in rats. We have recently synthesized two novel Marsanidine analogues which decrease blood pressure and heart rate in rats: 1-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-1H-indole (TCS-54), and 7-chloro-1-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-1H-indole (TCS-213). Among all these analogues, compound TCS-80 exhibits the highest affinity to I1-imidazoline receptors and the lowest α2/I1 selectivity ratio. The observed cardiovascular effects of the compounds might be mediated through α2-adrenergic and I1-imidazoline receptors and subsequent decrease of the symphathetic nerve activity. The present studies were performed to determine whether α2-adrenergic and/or I1-imidazoline receptors are involved in the decrease of blood pressure and heart rate induced by Marsanidine, TCS-54, TCS-80, and TCS-213 in rats.

Methods: Anesthetized rats were infused iv with the tested compounds and selective α2-adrenoceptor antagonist, RX821002, or nonselective α2-adrenergic/I1-imidazoline receptor antagonist, Efaroxan. The mean arterial blood pressure and heart rate were monitored directly and continuously throughout the experiment.

Results: Efaroxan inhibited the hypotensive effect of TCS-80 stronger than RX821002. The degree of inhibition of the hypotensive effect of the remaining compounds was similar for both antagonists. The presence of Efaroxan and RX821002 diminished the heart rate decrease induced by all compounds administration, though the influence on the maximal chronotropic effect was attenuated significantly in the TCS-80 and TCS-213 treated animals only.

Conclusion: Our results indicate that hypotensive and negative chronotropic activities of all tested compounds are mediated by both the α2-adrenergic and I1-imidazoline receptors. Moreover, the circulatory effect of TCS-80 might be mediated to relatively higher degree by the I1-imidazoline receptors than by the α2-adrenergic ones.

Keywords: Efaroxan; Hypotensive effect; Imidazoline compounds; Marsanidine; RX821002.

MeSH terms

  • Animals
  • Benzofurans / pharmacology
  • Blood Pressure / drug effects*
  • Heart Rate / drug effects*
  • Hypotension
  • Idazoxan / analogs & derivatives
  • Idazoxan / pharmacology
  • Imidazoles / antagonists & inhibitors
  • Imidazoles / chemical synthesis
  • Imidazoles / pharmacology*
  • Imidazolidines / antagonists & inhibitors
  • Imidazolidines / pharmacology
  • Imidazoline Receptors / drug effects
  • Imidazolines / antagonists & inhibitors
  • Imidazolines / chemical synthesis
  • Imidazolines / pharmacology
  • Indazoles / antagonists & inhibitors
  • Indazoles / chemical synthesis
  • Indazoles / pharmacology*
  • Male
  • Rats
  • Receptors, Adrenergic, alpha-2 / drug effects

Substances

  • 1-((imidazolidin-2-yl)imino)indazole
  • Benzofurans
  • Imidazoles
  • Imidazolidines
  • Imidazoline Receptors
  • Imidazolines
  • Indazoles
  • Receptors, Adrenergic, alpha-2
  • TCS-80
  • 2-methoxyidazoxan
  • efaroxan
  • Idazoxan